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Abstract This review presents the basic problems and
currently available molecular techniques used for genetic
profiling in disaster victim identification (DVI). The environ-
mental conditions of a mass disaster often result in severe
fragmentation, decomposition and intermixing of the remains
of victims. In such cases, traditional identification based on
the anthropological and physical characteristics of the victims
is frequently inconclusive. This is the reason why DNA
profiling became the gold standard for victim identification in
mass-casualty incidents (MCIs) or any forensic cases where
human remains are highly fragmented and/or degraded
beyond recognition. The review provides general information
about the sources of genetic material for DNA profiling, the
genetic markers routinely used during genetic profiling (STR
markers, mtDNA and single-nucleotide polymorphisms
[SNP]) and the basic statistical approaches used in DNA-
based disaster victim identification. Automated technological
platforms that allow the simultaneous analysis of a multitude
of genetic markers used in genetic identification (oligonucle-
otide microarray techniques and next-generation sequencing)
are also presented. Forensic and population databases con-
taining information on human variability, routinely used for
statistical analyses, are discussed. The final part of this review
is focused on recent developments, which offer particularly
promising tools for forensic applications (mRNA analysis,
transcriptome variation in individuals/populations and genetic
profiling of specific cells separated from mixtures).
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Disasters have accompanied humankind since time immemo-
rial. A disaster, as defined by the World Health Organization
(WHO), is “a sudden ecological phenomenon of sufficient
magnitudeto require externalassistance”.Itis importantthat,in
this definition, the emphasis is on the inability to provide
adequate assistance to all at need, rather than on the absolute
number of victims.
The traditional classification divides disasters into natural
and man-made ones. The first group includes floods, natural
fires, avalanches, earthquakes, tornadoes, volcanic eruptions,
droughts etc., while the events which fall into the other group
include transportation disasters (e.g. road traffic accidents,
rail, air and maritime transport disasters), construction
disasters, fires and wars.
Changes taking place in the modern world make the use
of weapons of mass destruction (e.g. biological, chemical)
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conflict and a terrorist act. These two events, war and
terrorism, are examples of intentional human actions; the
other examples are civilisational disasters which should be
considered as the price which today’s society has to pay for
what can be broadly defined as technological progress.
As early as 1628 BC, the eruption of Santorini in the
Aegean Sea was recorded—the biggest explosion since the
birth of human civilisation. Another was the eruption of
Vesuvius in 79 BC, which produced thousands of victims at
Pompeii and Herculaneum. The recent 2,000 years of human
civilisationalsoaboundedinvarioustypesofdisasters.Among
them, one may mention the plague epidemic, which claimed
75 million people in the years 1347–1351, explosions of
volcanoes in Indonesia in 1815 and 1833 (respectively, 90,000
and 40,000 deaths) or events in China, like flooding along the
river Huang-Ho in 1887 (one million victims), land slides in
the province of Kansu in 1920 (180,000 killed) or the blowing
upofadamontheYang-tse-kiangin1938(890,000deaths).In
the more recent times, the worst natural disasters include: the
cyclone in Bangladesh in 1970 (one million victims), the
earthquake in Tangsham, China, in 1976 (750,000 deaths) and
the earthquake in Haiti in January 2010 (230,000 deaths). The
most recent disaster occurred in 2011 in northeastern Japan,
where an earthquake with a force of about 9 degrees on the
Richter scale was followed by a tsunami. As a result, 28,000
people were killed or unaccounted for. A nuclear power plant
in Fukushima province was also severely damaged in the
aftermath. Because of the radiation hazard in the area within a
radius of 20 km from the power station, there was an urgent
need to evacuate the residents. Four months later, repeated
shocks complicated the situation even further, although they
did not cause any new fatalities. Other recent man-made
disasters include a chemical catastrophe in Bhopal, India, in
1984 (3,500 killed), the explosion of the Chernobyl nuclear
reactor in Ukraine in 1986 (between 31,000 and 75,000 killed,
dependingon the sourceofinformation) andtheterrorist attack
on the Twin Towers of the World Trade Center in New York
City on September 11, 2001, which killed nearly 3,000 people
and left over 6,000 wounded.
The official record of major disasters in Poland, kept since
the 1970s, shows several dramatic events, which challenged
national forensic genetic laboratories. These were: a gas
explosion in the Rotunda building in Warsaw in 1979 (49
killed, 100 wounded),the collisionoftwo trainsnearOtłoczyn
in 1980 (65 people killed, 64 injured), the sinking of the ferry
“Jan Hevelius” near Ruegen in the Baltic Sea in 1993 (55
killed), a fire in the hall of the shipyard in Gdansk during a
concert in 1994 (7 people killed, hundreds suffered burns), a
gas explosion in an apartment building in Gdansk in 1995 (22
people killed) and the collapse of the roof of the International
Fair Hall in Katowice during a pigeon exhibition in 2006 (64
people killed).
Air crashes have a special place among civilisational
catastrophes. Since 1970, there has been a steady increase
in the number of airplanes cruising the airspace, and a
record number of 46.3 million flight hours was reached in
2008. Airplane accidents occur primarily during the takeoff
and ascending phase of the flight, and the vast majority
occurs at a distance of 10 km from the runway. Although
air travel is considered to be the least risky of all forms of
transport (the probability is only one fatal accident per
million departures), several plane crashes worldwide are
recorded each year. Plane crashes are usually extremely
dramatic and they appear extremely shocking to public
opinion. In the collision of two Boeing 747 aircraft at Los
Rodeos airport in Tenerife in 1977 (flight numbers 1736
and 4805), 583 people were killed (61 passengers sur-
vived); in the biggest single-aircraft disaster (Boeing 747
again) in 1985 in Japan, 520 people were killed (flight
number 123) (four people survived).
Over the last 40 years, there has been a number of fatal
Polish airplane crashes: a crash near the Okecie Airport in
1980, with 87 people killed (flight number LO 007), another
one in the Kabacki forest near Warsaw in 1987, with 183
people killed (flight number LO 5055), and, especially, the
crash of a Polish government delegation flight near Smolensk
in 2010 (PLF 101-I-M), in which 96 people lost their lives
(among them, the President and his wife, parliamentarians,
commanders of the Polish armed forces, ministers and many
others).
One of the key issues during the disaster response is the
need to identify victims. Disaster victim identification (DVI)
can be performed in several traditional ways, like the physical
identification of documents, jewellery and other belongings.
More reliable methods are associated with the collection of
fingerprints, hair and/or dental data.
Until recently, in the vast majority of cases, traditional
methods were used for DVI, while DNA-typing played a
supporting role or was the last resort when other methods
failed. Currently, DVI is based mainly on molecular method-
ology, which is considered to be the most effective approach
in victim identification, both in small-scale disasters and in
mass-casualty events.
Early molecular biology procedures used for DVI were
based on the analysis of protein or blood group poly-
morphisms. Most of these systems (with the exception of
human leukocyte antigen [HLA]) suffered from a low
degree of discrimination and, in addition, their use was
limited because of an insufficient amount of genetic
information in many tissues and low stability in biologi-
cally degraded forensic samples (Budowle and van Daal
2008). In 1985, a quarter of a century ago, the first paper
describing the genetic identification of human individuals
by DNA fingerprint analysis was published (Jeffreys 1985).
This original approach, based on minisatellite hybridisation,
42 J Appl Genetics (2012) 53:41–60came to be known as DNA fingerprint analysis. Since then,
DNA analysis has undergone rapid evolution (Decorte
2010). The developments were instigated by the need for
more specific and more sensitive methods allowing identi-
fication based on less material of lower quality. The
introduction of polymerase chain reaction (PCR)-based
techniques allowed the targeting of a variety of genetic
markers, from single-nucleotide polymorphisms (SNP) to
variable number of tandem repeats (VNTRs); VNTRs include
minisatellites (repeated motif of 6–100 bp) and microsatellites
(repeated motif of 1–5 bp), often referred to as short tandem
repeats (STRs) or simple sequence repeats (SSRs). The
current methodology in genetic identification relies on the
useofdirectanalysisoftheDNAsequenceandtheavailability
of numerous genetic databases.
Human identity testing may be considered in a variety of
contexts: forensic casework, analysis of relationship,
paternity testing, missing person investigation and mass-
casualty incident (MCI) victim identification. Although the
ultimate goal is to obtain a match between two persons or
between a biological material and a person, the specific
context of each of these applications of human identity
testing has its specific problems, ranging from technical
approach, through statistical interpretation, to ethical issues.
The main focus of this review is on genetic profiling in
DVI.
Basic problems of genetic profiling in disaster victim
identification (DVI)
TheenvironmentalconditionsofanMCIoftenresultinsevere
fragmentation, decomposition and intermixing of the remains
of victims. In such situations, traditional identification
methods, based on the anthropological and physical
characteristicsofthevictims,fail.ThisisthereasonwhyDNA
profiling became the gold standard for victim identification in
MCI or any forensic cases when, for various reasons, the
human remains are highly fragmented and/or degraded
beyond recognition.
The primary goals of DNA profiling are determined by the
specificity of a catastrophe and may involve:
– Identification of the victims (by comparing to DNA
profiles from reference samples);
– Association of body parts (sometimes from highly
fragmented remains);
– In certain cases, the identification of perpetrators (often
from contact traces).
Depending on the primary goal, the procedures vary to a
considerable extent. For example, the identification of a
small part of the recovered remains is enough to identify
the person, but it does not satisfy the need to “reassemble”
the victim’s body for their family. On the other hand, the
DNA-based association of body parts does not assure the
personalidentificationofavictimifthereferenceDNAprofile
is not available.
The technical approach adopted in the process of DVI
has to take into account the possible problems which can be
associated with DNA profiling. Most of the difficulties are
related to:
– Scarcity and/or degradation of the analysable genetic
material;
– Non-homogeneous character of the material;
– Lack of informative reference samples.
The scarcity of DNA available for the analysis may reflect
the critically small amount of material used for DNA
extraction. The source material may come in the form of
contact traces, for example, on personal items of a victim (to
beusedasreferencesamples)oronforensicsamples(meantto
reveal the identity of a perpetrator). This problem influences
thechoiceofextractionmethods,ofDNAprofilingtechniques
and, to some extent, of markers to be analysed.
The scarcity of analysable DNA may also be related to its
degradation, which depends on the quality of the remains,
related to the circumstances of the catastrophe, to the time
elapsed since the victim’s death and to the environmental
conditions. The degree of degradation also depends on the
analysed tissue; for example, DNA from bones is usually less
degraded than that from blood or soft tissues; DNA from
blood is less degraded than that from saliva etc. (Dixon et al.
2006). If DNA degradation is very serious, it may present a
serious challenge to DVI in an open type of a catastrophe.
An inverse relation between the degradation and the length
of DNA sequence that can be successfully and reproducibly
analysed influences the choice of DNA profiling technology
and of markers to be analysed (Dixon et al. 2006).
The non-homogeneous character of the genetic material in
DVI depends on the circumstances of a catastrophe. In the
case of severe fragmentation of victims’ bodies, it may
compromise the association of body parts, while still allowing
the identification of the victims. The lack of material
homogeneity poses the most serious problems when identifi-
cation is to be based only on the analysis of contact traces
(e.g. in the identification of perpetrators). The mixed DNA
profiles of many individuals have a direct bearing on the
choice of markers to be analysed and on the statistical
methodology for the assessment of results.
Genetic methods used for the forensic identification of
individuals rely on the comparison of the material under
investigation with reference samples. Reference samples can
take the form of biological material or the victim’sp e r s o n a l
use items previously acquired (used in direct matching
analysis) or material obtained from the victim’s known
biological relatives (used in kinship analysis) (National
J Appl Genetics (2012) 53:41–60 43Institute of Justice 2006). In cases aiming to confirm the
identity of a victim in a “closed” type incident, obtaining
reference samples is relatively simple. The lack of informa-
tive reference samples presents the most serious challenge to
DVI in “open” type catastrophes involving a large and
precisely unknown number of victims of unknown identity.
In some cases, solving this problem can be aided by using
the information stored in a variety of specialised genetic
databases (containing DNA information of blood, sperm or
tissue donors, missing persons, criminals or victims etc.). An
alternative way to shed light on the genetic origin of an
unidentified biological sample is to compare it with
population-specific data. While not direct, this approach
allows the focus of further investigation to be narrowed. An
efficient approach to the genetic identification of individuals
based on population-specific data requires taking into account
general information on human genetic diversity and strongly
affects the choice of markers to be analysed.
Sources of material and extraction methods
for genetic profiling
Any type of biological remains (including soft tissue, bone,
saliva and hair) can be used as a source of genetic material for
DNA profiling (e.g. Mandrekar et al. 2002). However, the
quality of the genetic material to be analysed is strongly
influenced by the time since death and environmental
conditions. When using degraded and limited samples,
extraction methods have to be optimised for maximum yield
and typing success. The International Society for Forensic
Genetics (ISFG), building on experiences from recent mass
disasters, formulated recommendations concerning practical
procedures and guidance in the collection and storing of
ante-mortem and post-mortem samples suitable for the
DNA-based identification of victims (Prinz et al. 2007).
Obviously, the need for optimisation is even more pro-
nounced in cases when transcriptome profiling is considered
(Ibberson et al. 2009).
Factors suchashightemperature,contaminationofremains
withdirtorjetfuel,theputrefactionprocessormicrobiological
infestation, may significantly impair DNA quality. In compar-
isontosofttissues,hardtissuesaregreatlyresistanttoautolysis
and decay caused by environmental factors, which is why
bones, teeth and nails are the only source of DNA in some
forensic cases (Graw et al. 2000). The choice of an isolation
method depends on the type of biological remains and the
degree of body decay. A number of methods for DNA
extraction used in forensic applications have been tested for
their performance in various tissue types (from bones to soft
tissues) and under different environmental conditions (e.g.
moisture, air drought) (Clayton et al. 1995;G r e e n s p o o ne ta l .
1998; Hoff-Olsen et al. 1999; Butler 2005).
Phenol-chloroform extraction, which is considered to be
the most efficient method of obtaining high molecular weight
DNA, was successfully applied in many identification studies
using genetic profiling in decomposed body remains or in old
bone material (Kapińska and Szczerkowska 2004; Butler
2005). Presently, the implementation of PCR-based methods
alleviated the need for the extraction of high molecular
weight DNA, and new, faster and less chemically hazardous
methods are becoming more popular. Ion-exchange-based
methodology using Chelex resin is another DNA extraction
method routinely used in forensic casework. Polar resin
binds polar components, while denatured, non-polar nuclear
DNA and RNA remain in solution. In comparison to the
organic method, Chelex is more rapid, less prone to sample–
sample contamination and, in some cases, more efficient
(Sweet et al. 1996; Hoff-Olsen et al. 1999). Unfortunately,
Chelex methodology appears to be inefficient in the removal
of PCR inhibitors from old, degraded tissue samples
(Greenspoon et al. 1998; Hoff-Olsen et al. 1999). In silica-
based DNA extraction methods (e.g. QIAamp spin columns),
nucleic acids selectively adsorb on a silica support in the
presence of a high concentration of chaotropic salts, whereas
proteins and contaminations are washed away (Butler 2005).
Silica-based methods are labour-saving and easy to perform;
however, too short DNA fragments are not able to bind to a
silica surface, rendering these methods not appropriate in the
case of heavily degraded material (Greenspoon et al. 1998;
Butler 2005).
DNA purification kits based on magnetic beads have
become more dominant in the forensic laboratory in the last
few years. This technique relies on DNA binding to the
magnetic beads in an appropriate ionic charge of the
environmental surroundings; all un-bound contaminations
are washed away. Systems designed specifically for
forensic casework, for example, the DNA IQ™ System
(Promega) or the PrepFiler™Automated Forensic DNA
Extraction Kit (Life Technologies), enables DNA extrac-
tions from very small quantities of material, like bloodstain,
saliva or semen stain. The PrepFiler™Automated Forensic




prepfiler_autovalidation_bulletin.pdf). The biggest advan-
tages of the mentioned magnetic beads methodology is
labour-saving procedures, as well as the possibility of
automatisation, which is not only an attractive alterna-
tive to labour-intensive manual methods, but it is also is
more resistant against contamination or human error. A
variety of manufacturers offer automated machines for
the extraction of DNA from forensic samples. Regard-
less of the manufacturer, all systems allow robust, fast and
simultaneous isolation of several samples. Good DNA
44 J Appl Genetics (2012) 53:41–60recovery from low-yield samples using BioRobot EZ1 was
lately reported by different research groups (Nagy et al. 2005;
Kishore et al. 2006).
It is worth mentioning that the isolation of a relatively high
amountoftotalDNAfrombiologicalmaterialdoesnotalways
guarantee the positive determination of a proper genetic
profile. Genetic material extracted from human remains, in
addition to human DNA, often contains bacterial or fungal
DNA, which can act as inhibitors during the PCR assay
(Golenberg et al. 1996;G r e e n s p o o ne ta l .1998; Schmerer
et al. 1999).
Genetic markers used in DVI
The choice of genetic markers for DVI consistent with the
requirements discussed above reflects the fact that the
variability of the human genome is not uniform. This trivial
statement refers to a number of markers’ characteristics,
ranging from the distribution of markers in the genome, their
informativityandpopulationspecificity,tothetechnicalissues
of robustness to degradation processes and amenability to
multiplex and automated analysis. We further discuss the
characteristics of different markers and the technical
approaches presently used in personal genetic identification.
Short tandem repeats (STR) markers
The most frequently applied methodology of personal genetic
identification relies on STR profiling. The number of alleles of
the forensically relevant STR loci ranges usually from 5 to 20
common alleles (Budowle and van Daal 2008), and these
STRs are characterised by high values of polymorphic
informativity content (PIC) and have a high power of
individual discrimination (Chakraborty and Kidd 1991). The
multiallelic nature of STRs is a great advantage in analysing
mixtures, since, in many cases, alleles from multiple
contributors can be distinguished by means of their non-
overlapping size. STRs can be analysed in a multiplex
fashion, with as many as 16 loci amplified and typed
simultaneously (Krenke et al. 2002; Collins et al. 2004),
therefore, allowing the reduction of the amount of analysed
material. Early work with STRs involved detection on silver-
stained polyacrylamide gels, while the currently used
technology is based on fluorescence detection methods
involving gel or capillary electrophoresis and, more recently,
ABI gel-based DNA sequencers (Butler 2006).
The Federal Bureau of Investigation (FBI) uses, and has
done since 1997, a standard set of 13 specific STR loci,
collectively referred to as CODIS markers (TPOX, D3S1358,
D5S818, FGA, CSF1PO, D7S820, D8S1179, TH01, VWA,
D13S317, D16S539, D18S51 and D21S11), and the sex-
differentiating amelogenin locus AMEL-X/Y (Butler 2006).
The European Network of Forensic Science Institutes
(ENFSI) and the Council of the European Union (2001)
recommend a European Standard Set (ESS), which includes
seven loci: D3S1358, FGA, D8S1179, TH01, VWA, D18S51
and D21S11 (http://www.promega.com/resources/articles/
profiles-in-dna/2009/expansion-of-the-european-standard-
set/). ESS forms the core STR system used in European
national DNA databases; together with the amelogenin locus,
it is equivalent to the Interpol standard set of loci, ISSOL
(http://www.dna-conference.eu/ppt/Van%20der%20Beek.
pdf). The UK and much of Europe utilise the so-called
second-generation multiplex plus (SGMPLUS) profile, con-
sisting of eight loci from the CODIS core set (FGA, TH01,
VWA, D3S1358, D8S1179, D16S539, D18S51 and
D21S11), along with two additional markers, D2S1338 and
D19S433, and with the amelogenin locus (Butler 2006). A
variety of commercial kits are available for robust multiplex
amplification of the core STR loci (Butler 2006). For
example, the PowerPlex 16 kit (Promega Corporation)
amplifies the 13 core loci, two pentanucleotide loci, Penta
D and Penta E, and amelogenin (Krenke et al. 2002). The
16plex AmpFℓSTR Identifiler kit (Life Technologies) ampli-
fies the 13 core loci, two tetranucleotide loci, D2S1338 and
D19S433, and amelogenin (Collins et al. 2004). The analysis
of autosomal STR markers is often complemented by that of
Y-chromosome STRs, which are very valuable in kinship/
relationship testing; the commercially available Y-filer™ kit
types 16 Y-chromosome loci and amelogenin.
To improve the discrimination power as well as the success
in andeffectiveness of degradedDNA analysis,the ENFSIand
the European DNA Profiling Group (EDNAP) published in
2005 a list of three additional new mini-STR loci: D2S441,
D10S1248 and D22S1045, as well as two additional poly-
morphic loci, D1S1656 and D12S391 (Gill et al. 2006; Hill et
al. 2011). According to the ENFSI/EDNAP group’sr e c o m -
mendations, new and more robust kits have been developed
and introduced, e.g. the PowerPlex® ESX 17 and ESI 17
Systems (Promega Company) that allow the amplification of
17 loci (D1S1656, D2S441, D2S1338, D3S1358, D8S1179,
D10S1248, D12S391, D16S539, D18S51, D19S433,
D21S11, D22S1045, FGA, TH01, vWA, SE33 and the sex-
typing locus amelogenin) and the AmpFℓSTR® NGM™
PCR Amplification Kit (NGM) (Life Technologies), which is
partly compatible with AmpFℓSTR® kits to maximise
concordance with existing data sets (Hill et al. 2011).
Most of the STR markers used in commercial kits are
located on separate chromosomes (or are located over 25 Mb
apart). In most kits, full profiles of these independently
segregating STR markers provide a power of discrimination
rangingfrom1in10
10 t o1i n1 0
20, depending on the number
of markers used and the populations under investigation, e.g.
estimated random match probabilities for the US Caucasian
population, using PowerPlex16 and AmpFℓSTR Identifiler,
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18 (Butler 2006). Thanks to this high power of
discrimination, STR analysis has proven to be a powerful
tool in many mass fatality incidents since the 1990s. In fact,
in many instances, STR analysis alone was sufficient to
complete the DVI procedure.
In spite of being the most commonly and routinely applied
markers in forensics, STRs have some shortcomings, limiting
their use in DVI efforts. STRs are particularly informative on
well-preserved soft tissue and bone samples. In original
settings, theamplicon size was toolong (150–450 bp) to allow
efficient amplification from degraded DNA templates (Gill
2002). The development of mini-STRs (60–80 bp in length),
obtained by designing primers located closer to the tandem
repeat sequence, largely solved this problem (Wiegand and
Kleiber 2001; Butler et al. 2003; Coble and Butler 2005),
while maintaining consistency with the existing core loci.
However, the template size needed for the analysis (even
using mini-STRs) may still be too long to successfully
analyse heavily degraded samples.
Another shortcoming of using STRs is that further
extension of the set of 13–15 core loci, which, in some
cases, is necessary in order to achieve reliable discrimina-
tion, is not straightforward and the analysis is not fully
automated. Other potential technical problems include the
presence of triallelic patterns, null alleles, alleles with size
not matching the standardised allelic ladders etc. (Butler
2006). The high mutation rate of STR loci (10
−3–10
−5),
while rendering them very informative, also makes them
less stable (Huang et al. 2002; Dupuy et al. 2004). The
resulting problems with distinguishing the alleles identical
by state from those identical by descent compromise the use
of STRs in lineage or ethnicity analysis (Butler 2006).
Finally, STRs do not provide phenotypic hints regarding the
analysed samples.
Single-nucleotide polymorphism (SNP) markers
SNP markers offer a useful and increasingly important
extension to a routine STR-based DNA profiling. SNPs
provideanalmostunlimitedsourceofhumangenomediversity
to be analysed (Cooper et al. 1985;W a n ge ta l .1998).
Obviously, the number of over 30 mln refSNP clusters
reported in 2010 (build 132 of the NCBI dbSNP, http://www.
ncbi.nlm.nih.gov/projects/SNP/) includes variants which, be-
cause of the low frequency of their rare alleles, are not useful
for forensic identification. Based on the average nucleotide
diversity, estimated for the haploid human genome at 0.1%
(Li and Sadler 1991; Reich et al. 2002), one can expect a total
of about 3 million bases differentiating haploid genomes of
two randomly chosen individuals.
The application of SNP profiling for DNA identification
offers some advantages as compared to the use of STR
markers, but it also suffers from limitations. These positive
and negative aspects of using SNPs overlap, because the
required characteristic of a set of SNPs depends on their
specific applications (Budowle and van Daal 2008).
An important, general advantage of using SNPs for DVI
purposes stems from the possibility of analysing heavily
degraded fragments: SNPs can be amplified using DNA
templates of less than 60 bp in length (approximately the
length of two flanking primers). The biallelic nature of
SNPs facilitates their typing, but renders them not very
informative for identity testing on a per-locus basis. The
informativity may be increased by analysing many unlinked
SNPs, but, in order to achieve the level of discrimination
typical for the 13 core STR loci (i.e. 10
−15–10
−16), large
panels of SNPs (50–100) need to be genotyped (Chakraborty
et al. 1999;G i l l2001;L ie ta l .2006). Fortunately, the recent
progress in high-throughput technologies enables large
multiplex assays and complete automation of the process,
so that multiple SNP profiling is cost-effective and stand-
ardisable (see Automated technological platforms in genetic
identification). On the negative side, biallelic SNPs are more
difficult for interpretation in situations which involve
mixtures of contributing samples, since the deconvolution
of a mixed sample into individual profiles is difficult and not
reliable (Budowle and van Daal 2008).
AnimportantfeatureofautosomalSNPsisthattheyexhibit
considerable variability in their heterozygosity levels across
the genome. This is likely due to differences in the
recombination rate, as reflected by the presence of haplotype
blocks characterised by high levels of linkage disequilibrium
(Daly et al. 2001; Gabriel et al. 2002; Reich et al. 2002). The
extent of LD blocks in diverse human populations varies,
providing clues about the evolutionary history of human
lineages. On the other hand, genotyping a set of tightly
linked SNPs allows converting these biallelic markers into a
multiallelic haplotype. Autosomal SNPs within a single LD
block form lineage-specific markers, best known from the
analysis of maternally inherited mitochondrial DNA
(mtDNA) or paternally inherited non-recombining portion
of the Y-chromosome (NRY).
SNPs are characterised by a low mutation rate, on the order
of 10
−8/site/generation (Nachman and Crowell 2000;R e i c h
et al. 2002), which makes them stable genetic markers, with
alleles’ identity by state reflecting their identity by descent.
This is why differences in SNPs’ frequency and distribution
across ethnically diverse populations may be assumed to
represent their distinct evolutionary and demographic histo-
ries (Ziętkiewicz et al. 2001, 2003). Most studies of
autosomal, X- and Y-chromosome, and mtDNA markers
show higher levels of genetic variation in African compared
to non-African populations, reflecting the ancient history of
the origin of modern humans (Tishkoff and Williams 2002;
Zitkiewicz et al. 2001, 2003). Other differences in SNP
markers distribution reflect more recent demographic histo-
46 J Appl Genetics (2012) 53:41–60ries, such as migrations, population bottlenecks, isolation,
admixture etc. (Tishkoff and Verrelli 2003), and may be used
for inferring the geographic or ethnic origin of an individual.
The possibility of using SNPs for the inference of ethnic
origin of the analysed sample, which can help in predicting
the geographic origin or certain physical traits of a donor,
can be an important asset in DVI efforts, when no match is
found between the victim’s remains and any living person
or available database records. Mitochondrial SNP haplo-
types belong to continental-specific haplogroups and can be
used to indicate the matrilineal origin of the analysed
sample (the complementary patrilineal information most
often comes from the analysis of Y-chromosome STRs),
but their informativity is limited. The use of ancestry-
informative markers (AIMs), autosomal SNPs which are
characterised by large inter-population differences of their
allele frequencies, offers much better potential for assessing
the biogeographical origin of analysed samples (Frudakis
et al. 2003; Shriver and Kittles 2004; Phillips et al. 2009;
Nassir et al. 2009). Efficient discrimination of ancestry
requires genotyping a large number of AIMs, usually using
microarray-based technology. Currently available panels of
AIM SNPs (73 AIMs DNAWitness Bio-Geographical
Ancestry Kit, 320 AIMs Eurasian panel, 1,476 AIMs
European panel, references in Budowle and van Daal
[2008]) allow addressing continental differences and rela-
tive levels of admixture among some populations; addi-
tional panels will be required to reliably discriminate
between individuals from other specific populations within
continents (Budowle and van Daal 2008; Nassir et al. 2009;
Decorte 2010).
The complicated genetic background of DVI-relevant
physical traits (height, pigmentation, facial features) is the
reason why direct prediction of these traits from DNA
variabilitydatahasverylimitedsuccess(Sturm2009;D e c o r t e
2010). The basic approach relies on the identification of
SNPs within genomic regions (or genes) associated with a
particular trait. Some success has been achieved in revealing
the association of SNPs in a number of pigmentation
genes with various human hair, skin and eye colour
phenotypes: some sequence polymorphisms in the melano-
cortin 1 gene are indicators of the red hair phenotype, while
genome-wide association studies identified HERC2 as a
human iris colour gene (Grimes et al. 2001;R e e s2003;
Kayser et al. 2008).
In summary, the informed choice of SNPs for the
purpose of genetic identification has to combine informa-
tion on the technical and statistical aspects of SNP analysis
with that on SNPs’ population genetics and, at the same
time, taking into account the purpose of the study (Budowle
and van Daal 2008; Decorte 2010). A set of unlinked SNPs
characterised by high heterozygosity values and low inter-
population variance is suitable for personal identification,
where the assessment of match probability is based on the
allele frequencies in a general population (Dixon et al.
2005; Kidd et al. 2006; Sanchez et al. 2006). In contrast, in
cases where no match is found to relatives, reference
samples or personalised databases, using AIM-SNPs, may
help to establish the ethnicity of analysed samples, providing
important clues for further investigation (Phillips et al. 2009).
Finally, when SNP-based identification is to be based on
kinship analyses, the markers of choice are SNPs residing
on mtDNA or Y-chromosome loci, or lineage-specific
autosomal SNPs within genomic haploblocks (Budowle
and van Daal 2008).
Mitochondrial DNA (mtDNA) in forensic science
The analysis of nuclear markers may fail to give reliable
results, due to the degradation of nuclear DNA in the
available material or because of the insufficient amount of
DNA in samples like bones, hair shafts and teeth (Parson
et al. 2004; Parson and Bandelt 2007; Nilsson et al. 2008).
In such cases, mtDNA is a much more convenient marker,
due to its higher resistance to degradation and a high copy
number per cell. mtDNA analysis was first applied as court
evidence in 1996, in the case of Paul William Ware, who
was accused of a child rape and murder. The only exhibit
found at the crime scene was a single hair in the victim’s
throat, which, as mtDNA analysis indicated, belonged to the
suspect. Since then, mtDNA analysis has become an
increasingly frequent tool in forensic criminal casework
(Holland and Parson 1999).
Because of the lack of recombination, mtDNA can be
analysed as a single, highly informative multiallelic locus
(haplotype). This, together with the maternal mode of
inheritance, allows using the mtDNA of any maternally
related individual as a reference for personal identification
(Carracedo et al. 2000; Parson and Bandelt 2007). By
convention, mtDNA sequences (haplotypes) are recorded
by listing only the differences from the universal reference
sequence, also called the Cambridge or Anderson’ss e q u e n c e
(Isenberg and Moore 1999).
A big advantage of using mtDNA in forensic applica-
tions is its high sequence variation, which results from the
high mutation rate in the mitochondrial genome. mtDNA is
almost ten times more prone to mutation compared to
nuclear DNA. Two hypervariable segments of the control
region, HVSI (positions 16,024–16,365) and HVSII (73–
340), are the most variable between individuals, and are,
therefore, of special interest for forensic studies. Routine
investigation is based on a determination of sequence
variants of the mtDNA control region (PCR and sequenc-
ing). When an mtDNA profile derived from an evidence
sample matches that obtained from reference samples, the
statistical interpretation of a match significance depends on
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(Parson et al. 2004). If it is rare, the probability that the two
samples which share this haplotype are derived from the
same maternal line is high, and the evidence obtained in
this way has a strong discrimination power (Holland
and Parson 1999; Salas et al. 2007). In the European
population, where about 7% of the population share the
most common HVSI/HVSII type, standard sequencing
analysis of the control region is insufficient for forensic
discrimination. To improve the discrimination power,
SNPs located in the mtDNA coding region, which is more
evolutionarily stable, are analysed (Coble et al. 2004,
2006; Nilsson et al. 2008;D a c ae ta l .2008). As a result of
the growing number of completely sequenced mtDNA
genomes, a lot of SNPs have been published in the last few
years. For instance, population-specific SNP panels can
discriminate the population of Eastern Eurasia from that of
Western Eurasia. Some of these panels have been opti-
mised and successfully applied in forensic science labora-
tories (Brandstätter et al. 2003, 2006;Q u i n t á n se ta l .2004;
Daca et al. 2008).
Interpreting the weight of mtDNA evidence in forensic
testing is complicated by the non-homogeneous mutation
rate in the mitochondrial DNA genome. In some positions
(e.g. 16,093, 16,126, 16,172, 146, 150 and 152), mutations
are more frequent than in other sites. Heteroplasmy, the
presence of more than one mtDNA type in an individual, is
another uncommon feature of the mitochondrial genome,
which may complicate the interpretation of forensic
evidence. It may be observed at many levels; for example,
an individual can be heteroplasmic in one tissue type and
homoplasmic in another. Heteroplasmy usually manifests as
substitutions, but it can also affect the number of bases
residing within a homopolymeric stretch (for example, C
stretches) (Carracedo et al. 2000).
To standardise forensic mtDNA analysis, the DNA
Commission of the International Society for Forensic
Genetics created guidelines for mtDNA typing in a forensic
science laboratory. The relevant document regulates stan-
dard amplification and sequencing methodology, criteria for
inclusion or exclusion in case of mismatches between the
analysed samples, as well as general principles of hetero-
plasmy or indel interpretation (Carracedo et al. 2000; Tully
et al. 2001).
Statistical analysis in DVI
Statistics plays an important role in evaluating the eviden-
tial weight of DNA profiling, especially in more compli-
cated cases like those involving DNA mixtures and
subdivided populations (Fung et al. 2006). The underlying
theory and methodology are well developed (e.g. Balding
2005; Buckleton et al. 2005). The choice of an approach
used in DNA-based DVI reflects the compromise between
the quality of material available for analysis, the availability
of the reference material, the informativity of markers
analysed and the statistical threshold required to make the
identification.
The statistical threshold, which allows the conclusion
that a match between DNA profiles from a victim and from
a reference sample is not coincidental, may be calculated in
many ways (Butler 2006). In DVI work, the odds of a given
DNA profile favouring identification are represented as
likelihood ratios that permit DNA results to be combined
among multiple genetic systems or with other non-DNA
evidence. The likelihood ratio estimate is inversely related
to the random match probability, which, in turn, depends on
the genotype frequencies of the analysed markers, and
should be based on population-specific genotype frequen-
cies. The probability that a profile composed of multiple
independently segregating markers would accidentally
match any individual in the population can be estimated
as the product of genotype frequencies for all of these
markers. In a homogeneous population, the values of
random match probability for a profile composed of 13
STRs range from 1 in 10
14 to 1 in 10
21 (Butler 2005). The
National Research Council recommends taking population
structure into account when estimating random match
probabilities; this is especially important when the ethnic
origin of the person to be identified is unknown. If the
population structure and size are not known, the use of a
correction factor is advised: 0.01 for a large population and
0.03 for a small and isolated population where inbreeding
takes place. Such a correction causes a two orders of
magnitude reduction of the likelihood ratio, but when the
initial ratio is high (e.g. 10
22), this does not significantly
affect the results (Butler 2005).
One of the commonly used statistical approaches is based
on estimating Bayesian posterior probability, which combines
the odds of a given DNA profile favouring identification with
a prior probability. The prior probability describes the chance
that any sample of the available remains belongs to a
particular individual. Typically, it is inversely related to the
estimated number of victims N (in other words, the number
of victims strongly affects this a priori component, which,
only in case of typical paternity cases, is set as 50%). The
DNA laboratory has to analyse a set of markers yielding a
random match probability that, combined with the prior
probability, would meet the required posterior probability.
The posterior probability p of correctly identifying all N
victims is based on the formula (1−1/L)
N<p. For example, if
the required posterior probability in a catastrophe involving
N=1,000 victims is p=99.9%, the threshold for a random
match probability would have to be 1 in 10
9 (Brenner and
Weir 2003).
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using incorrect assumptions. The probability of a match
cannot be automatically translated into the probability of
identification (“prosecutor’s fallacy”); the theoretical prob-
ability of a match cannot be directly translated into practical
probability; the rates of laboratory errors (especially false-
positive probability) have to be taken into consideration;
population data have to be considered to compute a match
probability etc. Finally, a body part can be identified if its
DNA profile has a sufficient similarity to a direct personal
reference (DNA profile from a known biological relic of the
victim) to an indirect reference (DNA profile of the victim’s
family member) or to a profile in a database (“cold hit”); all
of these situations require different statistical approaches
(Brenner and Weir 2003).
Automated technological platforms
in genetic identification
A high level of multiplexing in genetic profiling is of special
importanceinDVI,wheretheaimistoanalysealargenumber
of informative markers in a limited amount of genetic
material. The ultimate level of multiplexing is represented
by the whole-genome approaches, allowing the simultaneous
analysisofamultitudeofgeneticmarkerswithouttheneedfor
their annotation. The recent progress in high-throughput
technologies enabled achieving unprecedented levels of
affordable automation and multiplexing of the genomic
sequence analysis. On the other hand, technologies are being
developed which make sequence analysis using single
molecule templates possible. All of these developments
opened new venues for forensic applications, including
DVI. Two main groups of recent technologies include
hybridisation to oligonucleotide microarrays and massively
parallel sequencing.
Hybridisation to oligonucleotide microarrays
Oligonucleotide microarray techniques (Sobrino et al. 2005)
are based on the hybridisation of target nucleic acids to
small, high-density arrays, containing tens of thousands of
short (~25 bp in length) synthetic oligonucleotides immobi-
lised on a solid support (chips or beads). A prior PCR
amplification of the region around the variable site is usually
required. The basic SNP genotyping techniques involve
allele-specific oligonucleotide hybridisation, primer exten-
sion and allele-specific oligonucleotide ligation.
Microarray technology has been first introduced for the
transcriptome analysis. Several microarray platforms for
RNA analysis have been developed by different companies
(e.g. Affymetrix and Illumina). They differ in the chemistry
and design of microarray preparation, and in detailed
protocols of RNA processing, labelling and hybridisation.
Protocols for template preparation typically include the
synthesis of cDNA from the total (poly-A) RNA isolated
from biological samples and in vitro transcription to
produce cRNA, which is then fragmented and used for
hybridisation with the microarray. The recent, most updated
version of the expression array produced by Affymetrix,
GeneChip Human Gene 1.0 ST Array, interrogates 28,869
well-annotated human genes with 764,885 distinct probes.
Each gene is represented on the array by approximately 26
probes, spread across the full length of the gene. The most
popular HumanHT-12 v4 Expression BeadChips system
produced by Illumina contains 12 arrays on a single
BeadChip, each with >47,000 probes derived from human
genes annotated in the NCBI Reference Sequence and
UniGene databases.
The alternative possibility of gene expression analysis,
accessible on the Illumina platform, DASL procedure
(cDNA mediated annealing, selection, extension and
ligation), is designed mainly for the analysis of partially
degraded RNA from formalin-fixed, paraffin-embedded
(FFPE) samples. Total RNA is reverse-transcribed to
cDNA; unique pairs of query oligos (one of which with
the unique gene address) are annealed to the cDNA and
subjected to primer extension and ligation. The products are
then PCR amplified in high multiplex, using common
primers, and hybridised (by means of the address sequence in
the query oligo) to the HumanRef-8 Expression BeadChip
designed to interrogate specific genes. This procedure could
be of special interest for forensic applications, as RNA
fragments as small as 60 bp may be addressed (Haller et al.
2006). HumanRef-8 Expression BeadChip allows the inter-
rogation of a specific set of 512 genes.
Microarray technology was later adapted for the genome
analysis, in particular, for SNPs genotyping and for
resequencing. There are many methods and commercial
platforms for SNP analysis. Here, we comment only on
those achievable on the Illumina and Affymetrix platforms.
Illumina offers BeadChips targeting from 300,000 to 2.5
million SNPs. The most advanced Affymetrix array, the
Genome-Wide Human SNP Array 6.0, contains probes for
about 906,600 SNPs. The sample preparation protocols are
similar for both platforms, although the amount of DNA is
about 2.5 times lower for Illumina (about 200 ng sample). An
important difference concerns the number of samples which
can be analysed during a single run: Illumina enables the
analysis of 2 to 12 samples, while Affymetrix allows the
examination of only one sample.
Targeted resequencing using microarrays consists of
microarray hybridisation, used for the template preparation,
followed by new-generation sequencing techniques (see the
next section). Illumina offers two kits for targeted rese-
quencing: TruSeq DNASamplePrep and TruSeq ExomeEn-
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capture library and processing of the DNA sample. After a
few cycles of DNA amplification, the enriched library is
loaded on an Illumina flow cell and undergoes standard
clonal amplification on the Illumina Cluster Station. After
that, clusters are generated and a flow cell is transferred to the
Genome Analyzer for massively parallel sequencing by
synthesis.SomekitsofferedbyAffymetrix,liketheGeneChip
Human Mitochondrial Resequencing Array 2.0, are based on
a similar sample preparation protocol.
Methylome analysis is offered exclusively by Illumina.
The Infinium Methylation Assay provides quantitative
methylation measurement at the single CpG-site level,
offering the highest resolution for understanding epigenetic
changes.
The DNA analysis using microarray technology has found
its application in forensic testing for sequencing or rese-
quencingpurposes,forSNPgenotyping,paternitytestingand
individual identification. SNP typing by oligonucleotide
probe microarrays designed to target 34 different SNPs was
evaluated in a sample of Chinese individuals; the study has
shown that the microarray assay was useful for paternity
testing and individual identification (Li et al. 2006).
Combined with the 28 SNPs loci distributed on HLA-
DRB1 and ABO genes (Li et al. 2004), the analysis of 59
SNP loci provided the discrimination power of 9 × 10
−15,
yielding, thus, the same power in forensic identification as
the CODIS STRs currently used.
On the other hand, the application of oligonucleotide
microarrays for DVI is not free of problems. For example,
evaluation of the Affymetrix GeneChip Mitochondrial
Resequencing Array for forensic applications in compari-
son to dideoxy fluorescent sequencing indicated that the
array platform had difficulty calling instances of point
heteroplasmy, insertions, deletions, poly C regions and
some closely spaced polymorphisms (Vallone et al. 2007).
The use of microarrays for identification on the basis of
RNA has been only rarely addressed and requires even
more research than DNA-based analysis. The potential
application of microarray-based analysis of the methylation
level for individual identification purposes also awaits
evaluation.
The main shortcoming of all of the described platforms is
that they contain only previously known, presynthesised
probes and, therefore, do not detect all of the nucleic acid
sequences present in the analysed biological samples.
Next-generation genome sequencing
Next-generation sequencing (NGS) allows the simultaneous
analysis of hundreds of loci or even of the whole genome,
without being dependent on genome annotation. NGS
produces massively parallel sequence data, in some cases
in excess of one billion short reads per instrument run
(Tucker et al. 2009; Li et al. 2009a; Harismendy et al. 2009;
Pareek et al. 2011). Cloning or template amplification of
the DNA fragments that are being sequenced is fully
automated and intimately coupled with the sequence reading
process. NGS provides an increased depth of sequence
coverage, which leads to a higher accuracy of the reads and
allows inferences on the copy number of analysed segments
(Tucker et al. 2009).
The three best-known NGS platforms are: Illumina
Genome Analyzer, ABI SOLID and Roche 454 Genome
Sequencer. All of them involve the template amplification
step, but they use different sequencing chemistries and
amplification approaches (Tucker et al. 2009). Illumina uses
bridge-PCR on a solid surface, while SOLID and 454
rely on PCR in emulsion; the sequencing chemistry is
polymerase-based (with fluorescently labelled nucleotides),
ligation-based and pyrosequencing, respectively. Illumina
and SOLID use fluorescent-based signal detection and 454
is based on the detection of light emitted upon pyrophos-
phate disintegration. The length of the reads is 75 bp for
Illumina GA, up to 50 bp for ABI SOLID and up to 400 bp
for Roche 454, while the raw base accuracy is 99.5% for
Illumina and Roche, and 99.94% for ABI Solid (Bosch
et al. 2008; Tucker et al. 2009).
The newer Helicos technology is a polymerase-based
method, which is unique in that it does not include the
amplification step and uses a single DNA molecule as a
template. The accuracy of the reads (30–35 bp) using this
platform is 99% (Braslavsky et al. 2003).
Most of the NGS platforms (except Roche 454) provide
very short reads (50–100 bp). While the possibility to read
very short sequences is an important advantage for
application to degraded DNA material, this characteristics
makes sequence assembly of repetitive and rearranged
DNA segments more difficult. Short length of the reads
also complicates interpretation when it is necessary to
determine the phase of variants, as in the case of mixed
DNA samples. Currently, NGS is more expensive in compar-
ison to the array-based technology. As this may change in the
future, a search for potential applications of NGS to DVI is
fully justified.
NGS can be used for both genome and transcriptome
analysis. In genome analysis, it permits high-quality variant
calling for SNPs, insertions and deletions, and allows the
analysis of copy number variants (CNVs) and other
structural rearrangements. In transcriptome analysis, NGS
can be used to annotate coding SNPs, discover transcript
isoforms, identify regulatory RNAs, characterise splice
junctions and determine the relative abundance of tran-
scripts. It allows to generate full sequence information from
any poly(A)-tailed RNA, analyse gene expression and
identify novel or rare transcripts in one experiment.
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could play a significant role in solving criminal cases and
the identification of human remains. Targeted sequencing of
candidate genes and genomic intervals in four individuals,
using Illumina GA, SOLID and 454, demonstrated the
suitability of NGS platforms for population-based targeted
sequencing studies, although it also indicated the need for
further optimisation (Harismendy et al. 2009). The biggest
disadvantage of NGS is a necessity of performing PCR
amplification that may introduce base sequence errors or
favour certain sequences over the other. Third-generation
HT-Technology, also known as sequencing from a single
DNA molecule, overcomes this problem because it is based
on sequencing by synthesis without any amplification step.
The available on the market HT-NGS platforms, offered by a
numberofcompanies,representadifferenttechnicalapproach
to sequencing by synthesis.
The newer Helicos technology is a polymerase-based
method, which is unique in that it does not include the
amplification step and uses a single DNA molecule as a
template. The accuracy of the reads (30–35 bp) using this
platform is 99% (Braslavsky et al. 2003).
SMRT sequencing technology is based on a single-
molecule, real-time sequencing. The process of enzymatic
incorporation of labelled nucleotides is performed on zero-
mode waveguides (ZMWs) located on the SMRT chip. The
whole process is captured by a CCD camera (http://www.
pacificbiosciences.com/smrt-biology/overview).
A different approach is represented by the Nanopore
DNA sequencer and Ion Torrent sequencing technology.
Both platforms are based on physicochemical processing
that occurs during the DNA sequencing process rather than
nucleotide labelling detection. In the Nanopore sequencer,
the DNA sequence is determined by the disruption of ionic
current in a protein nanopore, while Ion Torrent technology
is based on pH change caused by nucleotide incorporation
into a DNA strand. In contrast to all of the mentioned
platforms, PGM (Ion Personal Genome Machine) sequencer
is laser-capture-independent because it uses ion sensors
densely spaced on the bottom of a high-density array of
micro-machined wells. This new approach allows produc-
ing more sequence reads on time and faster gathering of
information than light-based technology platforms. It also
enables to perform a wider range of sequencing applications,
such as multiplexing amplicons, small RNA sequencing,
paired-end sequencing and methylation analysis (http://www.
iontorrent.com/; Pareek et al. 2011)
Examples of databases used for identification purposes
A multitude of databases are available, gathering information
of the human genome variability. While all can be, to some
e x t e n t ,u s e f u li nf o r e n s i c s ,o n l ys o m eo ft h e m ,w h i c hp r o v i d e
direct links between genetic variation and individuals, can be
directly applied in DVI procedures.
STR databases
The Combined DNA Index System, CODIS, stores STR-
based DNA profiles of US offenders and is organised in
two databases (indexes). The Convicted Offender Index
contains DNA profiles of individuals convicted of felony
sex offenses and other violent crimes; the Forensic Index
contains DNA profiles developed from crime scene
evidence. CODIS utilises dedicated computer software to
automatically search its two indexes for matching DNA
profiles. This technology is authorised by US law (DNA
Identification Act of 1994). As of August 2007, CODIS
contained over 5 million DNA profiles in its Convicted
Offender Index and about 188,000 DNA profiles collected
from crime scenes but not connected to a particular
offender (http://www2.fbi.gov/hq/lab/codis/clickmap.htm ).
Interpol and the European laboratories use a common
number of STRs (European Standard Set of loci, ESS) in
order to allow comparisons across borders. Their records
are stored in the National DNA databases (e.g. NDNAD in
the UK and FNAEG in France).
The drawback of using forensic databases as the source of
referenceinDNAprofilingforthepurposeofDVIisthatmost
of the data concern offenders and/or crime victims. Most of
the population never being involved in any forensic investi-
gation would have no matching records.
Population databases of genomic variation
In contrast to the personal information contained in the
forensic STR databases, the resources regarding SNP
markers are mostly population-oriented. dbSNP stores data
on SNP allele frequencies determined in four major
populations (http://www.ncbi.nlm.nih.gov/projects/SNP/).
The HapMap effort resulted in a large amount of data on
LD blocks, characterising SNP-based haplotypes, but this
information is again related to populations and not
individuals. Some STR databases also have a population-
rather than individual-based character, like the database of
Y-chromosome STR haplotypes (http://www.hapmap.org/)
(Thorisson et al. 2005). All of these resources, although not
directly usable for personal identification, may be used in
DVI efforts for the DNA-based determination of the
individual’s ancestry/ethnicity/geographic origin.
To evaluate the population frequency of Y-chromosome
haplotypes, the open-source YHRD database is commonly
recommended (Kayser et al. 2002; Jobling and Gill 2004).
This database contains haplotypes from the global popula-
tion from many continents, genotyped for a core set of
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DYS391, DYS392 and DYS393). The YHRD is divided
into sets of populations sharing a common linguistic,
genetic or geographic background. Such a structure is very
convenient during the statistical evaluation of haplotype
matches (Willuweit and Roewer 2007).
Helpful in estimating the frequency of mtDNA profiles
are some freely available public databases, which provide
information on mitochondrial haplotypes in a number of
populations. These databases contain data on total mtDNA
sequences (http://www.mtdb.igp.uu.se/), hypervariable
regions (HvrBase++) or mtDNA haplotypes (http://www.
nationalgeographic.com/genographic; Behar et al. 2007).
Another database storing mtDNA haplotypes, EMPOP
(http://empop.org/), is referred to as “forensic”, since the
data were collected in accordance with the requirements of
forensic data collection (Parson and Dür 2007). However,
unlike CODIS, this database does not allow personal
identification.
Some of the public mtDNA profile resources have been
heavily criticised for the unacceptably high rate of errors
(Bandelt et al. 2002, 2004; Yao et al. 2004). Mistaken
analysis or clerical errors introduced in the process of data
rewriting (Bandelt et al. 2001; Parson et al. 2004)r e s u l ti n
“phantom” polymorphisms, which disturb the assessment of
the population frequency of a particular mtDNA haplotype.
Although sources of these errors are well known, problems
still persist (Parson and Bandelt 2007). To solve the problem
of artifactual recombinations, phylogenetic analysis may be
applied, based on the knowledge of evolutionary patterns in
human mitochondrial genome (Parson and Bandelt 2007;
Salas et al. 2007).
The EMPOP database, recommended by the European
DNA Profiling (EDNAP) group, appears to be the most
inspected among the mtDNA databases. It contains about
12,785 mtDNA profiles from all of the continents, and
consists of forensic datasets obtained from forensic labora-
tories and literature data; all of the sequences have been
precisely verified in order to prevent the release of
erroneous data (Parson and Dür 2007; Zimmermann et al.
2011). Unlike many other databases, the EMPOP database
contains an application of quasi-median (QM) networks,
which is a powerful tool in the quality testing of mtDNA
data by graphically representing the genetic structure of the
lineages in a data set (Parson and Dür 2007; Zimmermann
et al. 2011).
A database’s size and coverage is another issue which is
very important in forensic identification based on mtDNA
analysis. Due to the very high level of variability in
mtDNA sequences, large databases are required to achieve
good representation of mtDNA diversity. Too small
haplotype coverage in a database, representing only a small
fraction of population diversity, results in wrong statistical
evaluation. This is especially important in a situation when
the suspect’s mtDNA haplotype is common in the relevant
geographical region, but has no appropriate representation
in the database (Salas et al. 2007). Analyses of Portuguese,
German and Polish populations indicated a lack of
saturation with respect to mtDNA haplotypes, using sample
sizes of 549 from the Portuguese population, 1,200 from
the German population and 1,253 from the Polish popula-
tion (Pfeiffer et al. 2001; Pereira et al. 2004; Daca et al.
2010). Even a large mtDNA database of the Genographic
Population Project, where 78,590 samples from distinct
regions of the world are stored, indicated a lack of full
haplotype coverage (Behar et al. 2007). This shows that a
constant database build-up is required for achieving an
appropriate representation of mtDNA haplotype diversity in
populations and that sample sizes used for forensic purposes
need to be very large.
Recent developments
New biotechnological methodologies and technologies are
constantly being developed. While their direct application
for DVI is often not possible at the present moment, these
alternative directions are worthy to be considered in the
context of developing new approaches for future efforts
aiming to identify individuals or to assess their population
affiliation.
mRNA analysis in present forensic applications
Successful recovery and cDNA amplification of mRNA
extracted from post-mortem tissues (Phang et al. 1994;
Cummings et al. 2001) or from tissue samples stored for
many years (Matsubara et al. 1992; Zhang and McCabe
1992; Karlsson et al. 2003) demonstrated the potential of
RNA for forensic studies. Real-time PCR results using
RNA extracted from various tissues indicated that RNA
degradation did not correlate with the post-mortem interval,
but, rather, with other parameters, like environmental
impact and circumstances of death (Li et al. 2004; Heinrich
et al. 2007). Today, body fluid identification (blood, saliva,
semen, vaginal secretion and menstrual blood) relying on
the quantification of specific mRNAs is an established
technique in many forensic laboratories (Juusola and
Ballantyne 2005; Nussbaumer et al. 2006; Zubakov et al.
2008); other possible applications (reviewed in Bauer 2007)
include wound age estimation (Takamiya et al. 2003) and
determination of the age of biological stains by means of
RNA decay analysis (Bauer et al. 2003; Anderson et al.
2005). Stable RNA markers were ascertained for the
identification of tissue specificity in old, degraded samples
(Zubakov et al. 2008, 2009).
52 J Appl Genetics (2012) 53:41–60Recently, the advances in multiplex real-time PCR
technology and the introduction of high-throughput se-
quence analysis platforms enabled the quantitative profiling
of the whole transcriptome. Importantly, quantitative
analysis of the transcriptome (using Illumina or Affymetrix
arrays addressing thousands of expressed genes) opened the
gates for the genome-wide analysis of differential levels of
gene expression in individuals and populations.
Transcriptome variation in individuals and populations
Many studies during the last decade have shown that gene
expression levels in humans differ not only among cell
types, but also among individuals. Allelic variation in
human gene expression has already been reported in 2002
(Yan et al. 2002). The following years brought a number of
microarray-based gene expression studies, addressing sev-
eral hundred to thousands of transcripts and performed in
tens to hundreds of human lymphoblastoid cell lines
(LCLs) derived from individuals of European ancestry.
These studies have shown that variation in human gene
expression is extensive, has a strong heritable component
and maps to many chromosomes across the human genome
(Cheung et al. 2003; Monks et al. 2004; Morley et al. 2004;
Cheung et al. 2005). The genome-wide linkage analysis in
LCLs from European CEPH families revealed the existence
of genetic determinants that acted in cis or trans to the
differentially expressed genes (Morley et al. 2004). Geno-
type data generated by the International HapMap Project
(The International HapMap Consortium 2003), used to test
for local and genome-wide association between expression
phenotypes and SNPs in unrelated CEPH individuals,
confirmed that both cis- and trans-acting loci regulate
variation in the expression levels of genes (Cheung et al.
2005; Stranger et al. 2005); significant associations of
genomic SNP regulators were more often detected at the
locations cis-proximal than distal and trans to the variably
expressed genes (Stranger et al. 2005).
These first studies, limited to transcriptome analysis in a
single European population, were soon followed by others,
designed to assess quantitative variation in gene expression
across populations (Spielman et al. 2007; Stranger et al.
2007; Storey et al. 2007; Price et al. 2008; Zhang et al.
2008). Analysed LCLs were derived from ethnically
homogeneous populations used in the International Hap-
Map Project (CEU – Utah individuals of European
ancestry, CHB – Han Chinese, JPT – Japanese, YRI –
Nigerians) as well as from an admixed population of
African Americans (AA). Expression phenotypes were
analysed using Illumina or Affymetrix arrays, which
addressed several thousand genes expressed in human
LCLs. Spielman et al. 2007 compared expression in 142
individuals from CEU, CHB and JPT populations. The
mean expression level of almost 25% of the genes differed
significantly between European and two combined Asian
populations; at the same time, significant differences in the
expression levels between CHB and JPT populations were
observed in 1–3% of the genes. Although the majority of
the expression differences were modest, taken collectively,
they allowed to significantly differentiate the analysed
populations. Storey et al. (2007), in a study performed in
16 CEU and YRI individuals, demonstrated that less
than ~17% of the genes were differentially expressed
among populations, while ~83% of the genes were
differentially expressed among individuals. This observa-
tion, resembling the distribution of human variance ob-
served at the DNA level, underlined the importance of
estimating how gene-expression variation is apportioned
within and among human populations. Zhang et al. 2008
evaluated gene expression in a much larger sample of 60
CEU and YRI parents–offspring trios. They estimated that
34–67% (depending on the thresholds used) genes were
differentially expressed between the two populations (using
more stringent cutoffs, 4.2−5.1% of the gene clusters were
differentially expressed). Stranger et al. (2007) performed
gene expression profiling in all of the 270 individuals
genotyped in the HapMap; differentiation between popula-
tions was in agreement with earlier small-scale studies. To
minimise the possible influence of non-genetic factors,
which could contribute to differential expression across
continental populations, Price et al. (2008) compared the
transcription levels in 89 African-American individuals.
The observed expression differences corresponded well to
those predicted by the variable proportions of two conti-
nental ancestries in African-American individuals (assessed
from the HapMap data), supporting the view that continen-
tal differences in transcriptome phenotypes were heritable
and directly linked to genomic variation.
Genome-wide association analyses using HapMap SNP
profiles, performed to elucidate genomic determinants of
transcriptomic differences across populations, yielded
results similar to those obtained for individuals from a
single population: population differences in the expression
levels were found to be associated with the differences in
SNP allelic frequencies (Spielman et al. 2007; Storey et al.
2007; Zhang et al. 2008). The most comprehensive, fine-
scale association analysis performed by Stranger et al.
(2007) addressed over 2.2 million common SNPs per
population in LCLs from all 270 individuals genotyped in
the phase II HapMap (The International HapMap Consortium
2008). Their results (~1,350 differentially expressed
genes with SNP association signals detected in cis
a n d~ 1 8 0i ntrans), strongly supported the prevalence of
genes with the expression regulated by cis-elements, but
did not exclude a significant contribution of trans-effects
that are often more indirect and, therefore, weaker and
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their study of African-Americans, estimated that only
12–13% of the expression phenotypes were due to cis
variants, indicating that distant or trans-acting elements
can contribute substantially to the population differences
in gene expression.
Although the exact contribution of cis or trans-acting
regulatory genomic elements to heritable variation in
expression remains to be established, the fact that gene
expression differences among populations and individuals
are associated with heritable DNA variation remains
unquestioned, justifying the potential use of transcriptome
analysis for determining the population specificity of the
analysed samples. Furthermore, a number of biological
processes were found to be enriched in the differentially
expressed and differentially spliced genes between conti-
nental samples (Stranger et al. 2007; Zhang et al. 2008). By
further analysing these processes, their possible roles in
contributing to the phenotypic population differences can
be revealed.
Determining whether associated SNPs are actual causative
factors of expression phenotypes remains a challenge, and
findings from genome-wide association studies need to be
confirmed and verified by functional analyses. Apart from the
possibility of just being linked to real regulators, SNP alleles
can be indicative of CNVs, can themselves influence
transcription or transcript stability or can be involved in
alternative splicing.
CNVs are a potential source of expression-level differ-
ences among individuals and/or populations. It was shown
that CNVs are sufficient to discriminate continental
populations and that CNVs involving genes modify, to a
certain extent, their expression levels (Armengol et al.
2009). However, transcriptome analysis in CEU and YRI
populations has shown that the majority of differential
expression phenotypes were not within genomic regions of
known CNVs, indicating that the possibility of CNVs being
major contributors to the expression differences is unlikely
(Zhang et al. 2008).
Alternative splicing is likely to play an important role
in regulating gene expression given the estimates that
between one-third and two-thirds of all human genes
may undergo alternative splicing (Sorek et al. 2004).
Analysis of the HapMap Project data in European LCLs
has recently shown that common genetic variation (SNPs)
correlates with heritable changes in alternative splicing
( H u l le ta l .2007;K w a ne ta l .2007). The genome-wide
association study using 176 LCLs from individuals of
European and African ancestry has shown that SNP variation
does contribute to a substantial fraction of transcript isoform
variationacrossthese populations,althoughsomenon-genetic
factors could also influence the observed differences (Zhang
et al. 2008).
In the last two years, attention was paid to the potential
of small non-coding RNA (ncRNA) profiling for tissue
identification (Hanson et al. 2009; Courts and Madea 2010;
Shah et al. 2010; Zubakov et al. 2010). Micro-RNAs
(miRNAs) are a class of evolutionary conserved ncRNA,
which post-transcriptionally control the expression of
protein coding genes in diverse cellular processes (Farh
et al. 2005; Lim et al. 2005; Shivdasani 2006). miRNA
profiling was shown to have greater potential to discrimi-
nate tissues and weakly differentiated cancers than mRNA
profiling (Lu et al. 2005; Liu et al. 2009). Moreover,
because of the small size of mature miRNAs (18 to 24
nucleotides), many authors consider them to be more stable
than mRNAs, which is highly relevant for forensic
purposes (Jung et al. 2010; Zubakov et al. 2010). Although
some authors observed that the degradation of miRNA in
degraded total RNA was random, leading to the unpredict-
ability of miRNA expression profiles (Ibberson et al. 2009),
the potential of miRNA to distinguish tissues remained
unquestioned. The differential expression of specifically
chosen sets of miRNAs was shown to allow for the
successful discrimination of several forensic body fluids
(Hanson et al. 2009; Zubakov et al. 2010). These studies
clearly demonstrated that the quantitative profiling of
miRNA—and possibly other classes of small ncRNAs—
opens new perspectives in the forensic analysis of degraded
samples (Courts and Madea 2010). However, little is
known about the population specificity of miRNA profiles
and further studies, aiming at rigorous methodological
validation and standardisation, are required before forensic
applications of miRNAs in DVI procedures become
possible.
Potential problems with using transcriptome analysis
in forensics
Using transcriptome analysis for tissue identification is
possible thanks to the fact that gene expression differs
across tissues and that, within a particular tissue or cell
type, it changes with time (e.g. depending on the RNA life
time and developmental stage of the organism) and in
response to external environmental conditions (diet, stress,
infectionetc.).Theseverycharacteristicsmakethe application
of expression profiling for the identification of individuals
and/or populations very challenging. Such applications
require an extensive effort to sieve away the effects of
tissue-specificandenvironmentallytriggereddifferencesfrom
the individual and population-specific variation in gene
expression.
The majority of the presently available data on differential
expression levels in individuals or populations are limited to a
model of lymphoblastoid cell lines (EBV-immortalised
B-cells). Expression phenotypes remain to be characterised
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more, the accurate assessment of the expression differences
among populations other than continental groups represented
byHapMapLCLsrequiresfurtherstudiesofthetranscriptome
in various human groups.
Ascertainment of genetic variants—SNPs, CNVs, splice
variants—associated with or underlying transcriptome
phenotypes that would stably and specifically differentiate
individuals, populations and tissues would require even
more rigorous standardisation, accounting for the complex-
ity of the genomic regulation of expression phenotypes.
This complexity was illustrated in the study by Dimas et al.
(2009), who performed gene expression profiling and
association with SNPs in three types of cells: LCLs,
T-cells and primary fibroblasts. They demonstrated that
the majority (80–90%) of genomic variants affecting gene
regulation act in a cell type-specific manner, and even
closely related cell types share only a minority of genomic
cis regulatory elements; in addition, multiple regulatory
SNPs existed per gene, unique or shared among cell types,
and positively correlated with the number of transcripts
per gene.
The application of transcriptome analysis for DVI poses
additional challenges, related to the degradation of the
biological material. While the degradation of the material
cannot be avoided, an accurate assessment of the RNA
template integrity remains a prerequisite for the reliable
interpretation of quantitative gene expression analysis
(Guhaniyogi and Brewer 2001). The commonly used ratio
of ribosomal RNAs (28S to 18S) was found to provide only
a weak correlation with RNA integrity (Auer et al. 2003;
Miller et al. 2004; Schroeder et al. 2006; Copois et al.
2007). Recently, an effective standardised algorithm,
called the RNA Integrity Number (RIN), was developed
(Schroeder et al. 2006). The RIN approach uses a
combination of microfluidics, microcapillary electrophore-
sis and fluorescence detection—the degradation of rRNA is
reflected by a continuous shift towards shorter fragment
sizes, providing values ranging from 10 (intact) to 1 (totally
degraded).
The non-homogeneous character of most forensic samples
presents another hindrance in the potential application of
transcriptome analysis for DVI purposes. Analysis in mixed
samples would require the deconvolution of signals specific
for populations, individuals, different tissues and environ-
mental factors.
Genetic profiling of specific cells separated
from heterogeneous mixtures
Forensic identification based on DNA or RNA profiles in
mixtures of samples is a challenging task (Torres et al.
2003). Although procedures to be applied in such situations
exist and have been used in forensic practice, they require
experience and complicated statistical evaluation (Clayton
et al. 1998; Butler 2005). As a rule, mixed genotypes have
a lower probative value. Interpretation is especially com-
plicated in cases of an unknown number of contributors and
their unbalanced proportion or different degree of degrada-
tion in the mixture (Torres et al. 2003). In such cases,
physical separation of cells at the very beginning of
investigation, allowing the isolation of pure cell populations
from heterogeneous samples, would provide the best
solution for forensic applications (Vandewoestyne and
Deforce 2010).
There are various methods for the physical separation of
cells. Differential lysis, filtration, sedimentation and ad-
sorption methods exploit the differences in physical
properties, like the shape and size of cells; fluorescence-
activated or magnetic-activated cell sorting rely on the
immunolabelling of cellular proteins (Vandewoestyne and
Deforce 2010). All of these methods have already been
applied in forensic investigations, mostly in rape cases, to
distinguish cells of the male offender from those of the
female victim (Witt et al. 1989, 1993). However, the
effectiveness of these methods (efficiency of separation
and yield of the specific cells) is limited, especially if the
amount of initial biological evidence is very small. Laser
capture microdissection (LCM) a technology combining
microscopy with laser beam technology, offers a more
suitable tool for the separation and collection of specific
cell pools from mixed samples (Curran et al. 2000; Elliott
et al. 2003; Li et al. 2009b; Vandewoestyne and Deforce
2010).
In LCM, specific cells are visualised via microscopy,
separatedfromtheothersusinglaserbeamenergyandisolated
into separate tubes, where the collected pools can be used for
direct DNA or RNA extraction and analysis (Curran et al.
2000; Vandewoestyne and Deforce 2010). The discrimina-
tion of different types of cells is one of the biggest challenges
in mixture separation by LCM. Fluorescence in situ hybrid-
isation (FISH) probes, specific for X and Y chromosomes,
are used to distinguish male from female cells. This
application becomes widespread in forensic investigations
of sexual assault cases with low numbers of sperm cells or
male/female mixtures of blood or epithelial cells (Anslinger
et al. 2005; Vandewoestyne and Deforce 2010). In medical
sciences, LCM is used in cancer research to determine the
cell-specific gene expression profile from heterogeneous
human tissues (Curran et al. 2000;C h o - V e g ae ta l .2005).
LCM can also be used for the isolation of blood cells from
different cell mixtures or to obtain DNA profiles from
biological samples contaminated with dirt or other compo-
nents which may inhibit genetic analysis.
The problem in DVI is that, when LCM is performed in
cells stained with histological stains, a stain providing good
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DNA quality (Vandewoestyne and Deforce 2010). DNA
profiling in mixed samples of the same sex would require
“barcoding” specific cells, for example, with FISH probes
specifically discriminating individuals (or populations).
Another technical difficulty of LCM-based DNA profiling
in mixtures is that the number of cells isolated by the
method is too small for routinely applied tools to extract
DNA. The most widely used, single-tube, DNA extraction
method after LCM is the method based on proteinase K.
Another recently developed technology (AmpliGrid slide,
Advalytix AG, Germany) uses chemically structured
microscope slides designed for ultra-low-volume applica-
tions. After the laser microdissection of cells (even of a
single cell) into one of the hydrophilic reaction sites on the
slide, DNA extraction and PCR can be performed directly
on these reaction sites (Schmidt et al. 2006; Vandewoestyne
and Deforce 2010). The combination of the AmpliGrid
technology with micromanipulation has been already
successfully applied by Li et al. (2009a) for a forensic
analysis of different types of material evidence (Li et al.
2009b). Since the first application of LCM to separate
spermatozoa from the victim’s cells (Elliott et al. 2003), this
technology has been used to separate cellular mixtures of
blood and saliva, to collect single hair follicles or to
distinguish foetal tissues from maternal tissues (Elliott et al.
2003; Budimlija et al. 2005; Vandewoestyne and Deforce
2010).
Conclusions
Mass-casualty incidents (MCIs) were present throughout the
whole history of mankind. Rapidly developing biotechnolo-
gies offer an almostperfect tool for victims identification. The
advantage of molecular genetic typing over any other method
of personal identification is obvious. However, this highly
complicated methodology is still undergoing development
and should not be considered uncritically. The major,
constantly debated technical topics are: how to deal with
sampledegradation,howtodecreasebackgroundsignals,how
to increase the sensitivity and specificity of the typing. In fact,
allofthesefactorsarisefromeachother,circulatinginaclosed
system of cause and effect.
Most countries allow classic DNA profiling, where
markers are located only in non-coding genome regions.
However, some of these non-coding markers are associated
with visible traits. Furthermore, many of the markers
provide information on an individual’s biogeographic
ancestry. Hence, the practical forensic application of
scientist-developed methodology may violate the spirit of
particular laws restricting the application of DNA analysis
in certain countries. Furthermore, DNA profiling laws
usually only cover samples taken from convicts or suspects
and from consenting volunteers, but these laws do not
include all traces to which molecular typing could be
applied. Many problems arise from a naïve adaptation of
existing molecular methodologies by users who have no
clue as to how deep the genetic insight into a personal
heritage could be. Civil-law systems in many countries
explicitly prohibit the determination of gender and race for
forensic purposes as an act conducive to racial and/or social
discrimination; this is especially important if the method-
ology is frequently applied for tracing suspects from
minority groups. Thus, a combination of common sense,
strict law enforcement and, above all, simple honesty is
required for the use of genome-based technologies for
particular purposes.
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